The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Clinical Applications of Metabolomics in Oncology: A Review
Open accessAbstract
Metabolomics, an omic science in systems biology, is the global quantitative assessment of endogenous metabolites within a biological system. Either individually or grouped as a metabolomic profile, detection of metabolites is carried out in cells, tissues, or biofluids by either nuclear magnetic resonance spectroscopy or mass spectrometry. There is potential for the metabolome to have a multitude of uses in oncology, including the early detection and diagnosis of cancer and as both a predictive and pharmacodynamic marker of drug effect. Despite this, there is lack of knowledge in the oncology community regarding metabolomics and confusion about its methodologic processes, technical challenges, and clinical applications. Metabolomics, when used as a translational research tool, can provide a link between the laboratory and clinic, particularly because metabolic and molecular imaging technologies, such as positron emission tomography and magnetic resonance spectroscopic imaging, enable the discrimination of metabolic markers noninvasively in vivo. Here, we review the current and potential applications of metabolomics, focusing on its use as a biomarker for cancer diagnosis, prognosis, and therapeutic evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
HMDB: the Human Metabolome Database
Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl923 · Cited by 3,231
Metabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Functional Genomics · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,167
Mass spectrometry‐based metabolomics
Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20108 · Cited by 2,241
Metabolomics--the link between genotypes and phenotypes.
Fiehn, O. (2002) · PubMed · Cited by 1,517
Roessner, U., Luedemann, A., Brust, D., Fiehn, O., Linke, T., Willmitzer, L., & Fernie, A. R. (2001) · The Plant Cell · doi:10.1105/tpc.13.1.11 · Cited by 1,017
Measuring the metabolome: current analytical technologies
Dunn, W. B., Bailey, N. J. C., & Johnson, H. E. (2005) · The Analyst · doi:10.1039/b418288j · Cited by 924
Metabolic profiles of cancer cells
Griffin, J. L., & Shockcor, J. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1390 · Cited by 725
Hasmann, M., & Schemainda, I. (2003) · PubMed · Cited by 617
Want, E. J., O'Maille, G., Smith, C. A., Brandon, T. R., Uritboonthai, W., Qin, C., Trauger, S. A., & Siuzdak, G. (2006) · Analytical Chemistry · doi:10.1021/ac051312t · Cited by 564
Cited by
Kather, J. N., Krisam, J., Charoentong, P., Luedde, T., Herpel, E., Weis, C.-A., Gaiser, T., Marx, A., Valous, N. A., Ferber, D., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002730 · Cited by 1,082
Metabolic phenotyping in clinical and surgical environments
Nicholson, J. K., Holmes, E., Kinross, J. M., Darzi, A. W., Takats, Z., & Lindon, J. C. (2012) · Nature · doi:10.1038/nature11708 · Cited by 546
Serum metabolomics for early diagnosis of esophageal squamous cell carcinoma by UHPLC-QTOF/MS
Wang, J., Zhang, T., Shen, X., Liu, J., Zhao, D., Sun, Y., Wang, L., Liu, Y., Gong, X., Liu, Y., et al. (2016) · Metabolomics · doi:10.1007/s11306-016-1050-5 · Cited by 373
High‐Throughput Metabolomics by 1D NMR
Vignoli, A., Ghini, V., Meoni, G., Licari, C., Takis, P. G., Tenori, L., Turano, P., & Luchinat, C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804736 · Cited by 365
Buescher, J. M., Moco, S., Sauer, U., & Zamboni, N. (2010) · Analytical Chemistry · doi:10.1021/ac100101d · Cited by 340
Metadata
- Authors
- Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G.
- Venue
- Clinical Cancer Research
- Published
- 2009-01-15
- Volume
- 15
- Issue
- 2
- Pages
- 431-440
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2107363389
- Cited by
- 753
- References
- 78
- FWCI
- 17.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Applications of Metabolomics in Oncology: A Review. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-08-1059
- The paper
- Spratlin, J. L., Serkova, N. J., & Eckhardt, S. G. (2009). Clinical Applications of Metabolomics in Oncology: A Review. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-08-1059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.